Time‐course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6‐hydroxydopamine in the rat: new clues from an old model
Identifieur interne : 000F27 ( Main/Exploration ); précédent : 000F26; suivant : 000F28Time‐course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6‐hydroxydopamine in the rat: new clues from an old model
Auteurs : Fabio Blandini [Italie] ; Giovanna Levandis [Italie] ; Eleonora Bazzini [Italie] ; Giuseppe Nappi [Italie] ; Marie-Therese Armentero [Italie]Source :
- European Journal of Neuroscience [ 0953-816X ] ; 2007-01.
English descriptors
Abstract
Despite the progressive development of innovative animal models for Parkinson's disease, the intracerebral infusion of neurotoxin 6‐hydroxydopamine (6‐OHDA) remains the most widely used means to induce an experimental lesion of the nigrostriatal pathway in the animal, due to its relatively low complexity and cost, coupled with the high reproducibility of the lesion obtained. To gain new information from such a classic model, we studied the time‐course of the nigrostriatal damage, metabolic changes in the basal ganglia nuclei (cytochrome oxidase activity) and behavioural modifications (rotational response to apomorphine) following unilateral injection of 6‐OHDA into the corpus striatum of rat, over a 4‐week period. Striatal infusion of 6‐OHDA caused early damage of dopaminergic terminals, followed by a slowly evolving loss of dopaminergic cell bodies in the substantia nigra pars compacta, which became apparent during the second week post‐injection and peaked at the 28th day post‐infusion; the rotational response to apomorphine was already present at the first time point considered (Day 1), and remained substantially stable throughout the 4‐week period of observation. The evolution of the nigrostriatal lesion was accompanied by complex changes in the metabolic activity of the other basal ganglia nuclei investigated (substantia nigra pars reticulata, entopeduncular nucleus, globus pallidus and subthalamic nucleus), which led, ultimately, to a generalized, metabolic hyperactivity, ipsilaterally to the lesion. However, peculiar patterns of metabolic activation, or inhibition, characterized the post‐lesional responses of each nucleus, in the early and intermediate phases, with peculiar response profiles that varied closely related to the functional position occupied within the basal ganglia circuitry.
Url:
DOI: 10.1111/j.1460-9568.2006.05285.x
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Time‐course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6‐hydroxydopamine in the rat: new clues from an old model</title><author><name sortKey="Blandini, Fabio" sort="Blandini, Fabio" uniqKey="Blandini F" first="Fabio" last="Blandini">Fabio Blandini</name></author><author><name sortKey="Levandis, Giovanna" sort="Levandis, Giovanna" uniqKey="Levandis G" first="Giovanna" last="Levandis">Giovanna Levandis</name></author><author><name sortKey="Bazzini, Eleonora" sort="Bazzini, Eleonora" uniqKey="Bazzini E" first="Eleonora" last="Bazzini">Eleonora Bazzini</name></author><author><name sortKey="Nappi, Giuseppe" sort="Nappi, Giuseppe" uniqKey="Nappi G" first="Giuseppe" last="Nappi">Giuseppe Nappi</name></author><author><name sortKey="Armentero, Marie Herese" sort="Armentero, Marie Herese" uniqKey="Armentero M" first="Marie-Therese" last="Armentero">Marie-Therese Armentero</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:7C5A4ABE21FFFB43C8CB778DB5A55DF5EB7D7C7C</idno><date when="2007" year="2007">2007</date><idno type="doi">10.1111/j.1460-9568.2006.05285.x</idno><idno type="url">https://api.istex.fr/document/7C5A4ABE21FFFB43C8CB778DB5A55DF5EB7D7C7C/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002707</idno><idno type="wicri:Area/Main/Curation">002366</idno><idno type="wicri:Area/Main/Exploration">000F27</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Time‐course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6‐hydroxydopamine in the rat: new clues from an old model</title><author><name sortKey="Blandini, Fabio" sort="Blandini, Fabio" uniqKey="Blandini F" first="Fabio" last="Blandini">Fabio Blandini</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Laboratory of Functional Neurochemistry, IRCCS Neurological Institute ‘C. Mondino’, Pavia</wicri:regionArea><wicri:noRegion>Pavia</wicri:noRegion></affiliation></author><author><name sortKey="Levandis, Giovanna" sort="Levandis, Giovanna" uniqKey="Levandis G" first="Giovanna" last="Levandis">Giovanna Levandis</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Laboratory of Functional Neurochemistry, IRCCS Neurological Institute ‘C. Mondino’, Pavia</wicri:regionArea><wicri:noRegion>Pavia</wicri:noRegion></affiliation></author><author><name sortKey="Bazzini, Eleonora" sort="Bazzini, Eleonora" uniqKey="Bazzini E" first="Eleonora" last="Bazzini">Eleonora Bazzini</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Laboratory of Functional Neurochemistry, IRCCS Neurological Institute ‘C. Mondino’, Pavia</wicri:regionArea><wicri:noRegion>Pavia</wicri:noRegion></affiliation></author><author><name sortKey="Nappi, Giuseppe" sort="Nappi, Giuseppe" uniqKey="Nappi G" first="Giuseppe" last="Nappi">Giuseppe Nappi</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Laboratory of Functional Neurochemistry, IRCCS Neurological Institute ‘C. Mondino’, Pavia</wicri:regionArea><wicri:noRegion>Pavia</wicri:noRegion></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neurology and Otorhinolaryngology, University of Rome ‘La Sapienza’, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author><author><name sortKey="Armentero, Marie Herese" sort="Armentero, Marie Herese" uniqKey="Armentero M" first="Marie-Therese" last="Armentero">Marie-Therese Armentero</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Laboratory of Functional Neurochemistry, IRCCS Neurological Institute ‘C. Mondino’, Pavia</wicri:regionArea><wicri:noRegion>Pavia</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">European Journal of Neuroscience</title><idno type="ISSN">0953-816X</idno><idno type="eISSN">1460-9568</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2007-01">2007-01</date><biblScope unit="volume">25</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="397">397</biblScope><biblScope unit="page" to="405">405</biblScope></imprint><idno type="ISSN">0953-816X</idno></series><idno type="istex">7C5A4ABE21FFFB43C8CB778DB5A55DF5EB7D7C7C</idno><idno type="DOI">10.1111/j.1460-9568.2006.05285.x</idno><idno type="ArticleID">EJN5285</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0953-816X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>apomorphine</term><term>cytochrome oxidase</term><term>striatum</term><term>substantia nigra</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Despite the progressive development of innovative animal models for Parkinson's disease, the intracerebral infusion of neurotoxin 6‐hydroxydopamine (6‐OHDA) remains the most widely used means to induce an experimental lesion of the nigrostriatal pathway in the animal, due to its relatively low complexity and cost, coupled with the high reproducibility of the lesion obtained. To gain new information from such a classic model, we studied the time‐course of the nigrostriatal damage, metabolic changes in the basal ganglia nuclei (cytochrome oxidase activity) and behavioural modifications (rotational response to apomorphine) following unilateral injection of 6‐OHDA into the corpus striatum of rat, over a 4‐week period. Striatal infusion of 6‐OHDA caused early damage of dopaminergic terminals, followed by a slowly evolving loss of dopaminergic cell bodies in the substantia nigra pars compacta, which became apparent during the second week post‐injection and peaked at the 28th day post‐infusion; the rotational response to apomorphine was already present at the first time point considered (Day 1), and remained substantially stable throughout the 4‐week period of observation. The evolution of the nigrostriatal lesion was accompanied by complex changes in the metabolic activity of the other basal ganglia nuclei investigated (substantia nigra pars reticulata, entopeduncular nucleus, globus pallidus and subthalamic nucleus), which led, ultimately, to a generalized, metabolic hyperactivity, ipsilaterally to the lesion. However, peculiar patterns of metabolic activation, or inhibition, characterized the post‐lesional responses of each nucleus, in the early and intermediate phases, with peculiar response profiles that varied closely related to the functional position occupied within the basal ganglia circuitry.</div></front></TEI><affiliations><list><country><li>Italie</li></country><region><li>Latium</li></region><settlement><li>Rome</li></settlement></list><tree><country name="Italie"><noRegion><name sortKey="Blandini, Fabio" sort="Blandini, Fabio" uniqKey="Blandini F" first="Fabio" last="Blandini">Fabio Blandini</name></noRegion><name sortKey="Armentero, Marie Herese" sort="Armentero, Marie Herese" uniqKey="Armentero M" first="Marie-Therese" last="Armentero">Marie-Therese Armentero</name><name sortKey="Bazzini, Eleonora" sort="Bazzini, Eleonora" uniqKey="Bazzini E" first="Eleonora" last="Bazzini">Eleonora Bazzini</name><name sortKey="Levandis, Giovanna" sort="Levandis, Giovanna" uniqKey="Levandis G" first="Giovanna" last="Levandis">Giovanna Levandis</name><name sortKey="Nappi, Giuseppe" sort="Nappi, Giuseppe" uniqKey="Nappi G" first="Giuseppe" last="Nappi">Giuseppe Nappi</name><name sortKey="Nappi, Giuseppe" sort="Nappi, Giuseppe" uniqKey="Nappi G" first="Giuseppe" last="Nappi">Giuseppe Nappi</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F27 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000F27 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:7C5A4ABE21FFFB43C8CB778DB5A55DF5EB7D7C7C
|texte= Time‐course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6‐hydroxydopamine in the rat: new clues from an old model
}}
| This area was generated with Dilib version V0.6.23. |  |